Hover Icons

Take an Active Approach to Hemostasis

FLOSEAL consists of a unique combination of patented gelatin granules and human thrombin to provide fast
(2 min median time to hemostasis),1 effective hemostasis. Learn more about how FLOSEAL works.

Convenient to Use

All-in-one package with human thrombin and pre-filled sodium chloride syringe, with no refrigeration required1
Floseal can be applied focally at the target site of bleeding1*
Needle-free kits available in both 5 mL and 10 mL sizes can now be used up to 8 hours after mixing with thrombin solution1
*Please refer to the applicable Instructions For Use for complete application techniques
*Do not apply Floseal Matrix in the absence of active blood flow.
Floseal is an effective adjunct hemostatic agent proven in a wide-range of bleeding scenarios1 with a proprietary combination of two independent hemostatic agents.1, 2
As a leader in hemostasis, we are committed to providing innovative solutions for surgeons. Floseal is effective across surgical specialties 1, and is proven to:
1. Stop bleeding 96% of the time within 10 minutes (first lesion, per-protocol analysis)1
2. Control bleeding in fully heparinized cardiac patients1,2
3. Stop bleeding fast (1.5 minutes median time to hemostasis) at the site of action1,4 in spinal surgery
4. Work on wet, actively bleeding tissue1
5. Conform to irregular wound surfaces3
5. Be effective on both bone and soft tissue1,4
6. Do not inject or compress FLOSEAL Matrix into blood vessels
Rx Only. For safe and proper use of this device, refer to the full Instructions for Use.

The Leader in Hemostasis

For certain surgical procedures, use of FLOSEAL Hemostatic Matrix is associated with shorter length of surgery,6 fewer intensive care unit days,7 significantly lower risks of minor complications, blood transfusions and surgical revisions.6

Consistent Performance

FLOSEAL has been proven to perform fast and consistently across a range of bleeds.8*

*Based on pre-clinical data.

Health Economic Benefits

The use of FLOSEAL can result in improved Resource Utilization Outcomes and substantial Cost Savings for hospitals – up to $1.5M per year for a hospital performing 245 mixed cardiac surgical procedures per year9 and $2,445 per spine procedure.10

Choose Better Outcomes.
Choose FLOSEAL.

Inadequate surgical hemostasis and uncontrolled bleeding may lead to transfusion and/or other bleeding-related complications,3 lower clinical outcomes and higher hospital costs.
For the last 20+ years, FLOSEAL Hemostatic Matrix has been shown to result in better clinical and hospital resource utilization outcomes.

FLOSEAL Hemostatic Matrix

FLOSEAL Matrix is indicated in surgical procedures (other than ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.